Status:
UNKNOWN
Cytoprotective Effect and Clinical Outcome of Perioperative Proesterone in Brain Tumors
Lead Sponsor:
Minia University
Conditions:
Diffuse Traumatic Cerebral Edema
Eligibility:
All Genders
20-65 years
Phase:
PHASE1
Brief Summary
Neuronal injury is evident in elective craniotomy for space occupying lesions. Surgical trauma and mechanichal impact of the tumor causes neuronal injury. Neurosreroid progesterone is a neurotransmitt...
Detailed Description
Progesterone is a natural neurosteroid that we are trying to use to impede both direct neuronal injury cauesd by and indirectly by surgical trauma. Progesterone can decreas vasogenic brain oedema. Our...
Eligibility Criteria
Inclusion
- All elective brain tumors elligible for craniotomy
Exclusion
- Refusal to participare
- Emergency craniotomy
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2020
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04414020
Start Date
June 1 2020
End Date
September 30 2020
Last Update
June 4 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine
Al Minyā, Abohelal, Egypt, 6115
2
Faculty of Medicine
Minya, Abohelal, Egypt, 6115